160 related articles for article (PubMed ID: 36846137)
21. The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling.
Luo A; Wu Z; Li S; McReynolds CB; Wang D; Liu H; Huang C; He T; Zhang X; Wang Y; Liu C; Hammock BD; Hashimoto K; Yang C
J Transl Med; 2023 Feb; 21(1):71. PubMed ID: 36732752
[TBL] [Abstract][Full Text] [Related]
22. Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic hypoperfusion in mice.
Chen Y; Tian H; Yao E; Tian Y; Zhang H; Xu L; Yu Z; Fang Y; Wang W; Du P; Xie M
Sci Rep; 2017 Aug; 7(1):7758. PubMed ID: 28798352
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.
Ulu A; Appt S; Morisseau C; Hwang SH; Jones PD; Rose TE; Dong H; Lango J; Yang J; Tsai HJ; Miyabe C; Fortenbach C; Adams MR; Hammock BD
Br J Pharmacol; 2012 Mar; 165(5):1401-12. PubMed ID: 21880036
[TBL] [Abstract][Full Text] [Related]
24. Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling.
Zhou C; Huang J; Li Q; Nie J; Xu X; Wang DW
Sci Rep; 2017 Jul; 7(1):6926. PubMed ID: 28761179
[TBL] [Abstract][Full Text] [Related]
25. 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
Bukhari IA; Alorainey BI; Al-Motrefi AA; Mahmoud A; Campbell WB; Hammock BD
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8143-8150. PubMed ID: 32767352
[TBL] [Abstract][Full Text] [Related]
26. Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice.
Tian Y; Yuan X; Wang Y; Wu Q; Fang Y; Zhu Z; Song G; Xu L; Wang W; Xie M
Neurochem Int; 2021 Nov; 150():105197. PubMed ID: 34592333
[TBL] [Abstract][Full Text] [Related]
27. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.
Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT
Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model.
Shen Y; Peng W; Chen Q; Hammock BD; Liu J; Li D; Yang J; Ding J; Wang X
Brain Behav Immun; 2019 Oct; 81():535-544. PubMed ID: 31306773
[TBL] [Abstract][Full Text] [Related]
29. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
[TBL] [Abstract][Full Text] [Related]
30. TPPU protects tau from H
Yao ES; Tang Y; Liu XH; Wang MH
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):785-790. PubMed ID: 27924507
[TBL] [Abstract][Full Text] [Related]
31. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
[TBL] [Abstract][Full Text] [Related]
32. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
[TBL] [Abstract][Full Text] [Related]
33. Endothelial Nox4 dysfunction aggravates atherosclerosis by inducing endoplasmic reticulum stress and soluble epoxide hydrolase.
Yu W; Li S; Wu H; Hu P; Chen L; Zeng C; Tong X
Free Radic Biol Med; 2021 Feb; 164():44-57. PubMed ID: 33418110
[TBL] [Abstract][Full Text] [Related]
34. sEH-derived metabolites of linoleic acid drive pathologic inflammation while impairing key innate immune cell function in burn injury.
Bergmann CB; McReynolds CB; Wan D; Singh N; Goetzman H; Caldwell CC; Supp DM; Hammock BD
Proc Natl Acad Sci U S A; 2022 Mar; 119(13):e2120691119. PubMed ID: 35312372
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Chronic Ethanol-Induced Cardiac Fibrosis by Restoring Autophagic Flux.
Zhou C; Huang J; Li Q; Zhan C; He Y; Liu J; Wen Z; Wang DW
Alcohol Clin Exp Res; 2018 Oct; 42(10):1970-1978. PubMed ID: 30047995
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
[TBL] [Abstract][Full Text] [Related]
37. Soluble epoxide hydrolase inhibitor promotes the healing of oral ulcers.
Li J; Wen Z; Lou Y; Chen J; Gao L; Li X; Wang F
Clinics (Sao Paulo); 2023; 78():100208. PubMed ID: 37148830
[TBL] [Abstract][Full Text] [Related]
38. Soluble Epoxide Hydrolase Inhibition and Epoxyeicosatrienoic Acid Treatment Improve Vascularization of Engineered Skin Substitutes.
Supp DM; Hahn JM; McFarland KL; Combs KA; Lee KS; Inceoglu B; Wan D; Boyce ST; Hammock BD
Plast Reconstr Surg Glob Open; 2016 Dec; 4(12):e1151. PubMed ID: 28293507
[TBL] [Abstract][Full Text] [Related]
39. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
40. Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.
Zhou Y; Liu T; Duan JX; Li P; Sun GY; Liu YP; Zhang J; Dong L; Lee KSS; Hammock BD; Jiang JX; Guan CX
Shock; 2017 May; 47(5):638-645. PubMed ID: 27753791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
